Pauline Funchain

18PUBLICATIONS
219CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Medical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 25, 2026
Evolving Landscape of Immunotherapy in Melanoma.

|Oct 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.

Jennifer M Wiggins, Qiao Zhang, Yian Zhang

|Oct 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.

Ling Zhu, Yee-Ming M Cheung, Cherie Chiang

|Jan 27, 2025
Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.

David J Savage, Benjamin Switzer, Rujul Parikh

|Nov 07, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.

Kathleen Conway, Sharon N Edmiston, Amanda Vondras

|Apr 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics.

Yee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel

Pageof 3

Frequent Collaborators

5 joint publications

Marc S Ernstoff

4 joint publications

Michael B Atkins

3 joint publications

Umang Swami

3 joint publications

John M Kirkwood